
Endoscope Reprocessing 2.0: Navigating the Latest Trends and Best Practices
Includes a Live Web Event on 09/25/2025 at 2:00 PM (EDT)
-
Register
- Learner - Free!
- Premium Member - Free!
Hit the green "Register (Free!)" button to register yourself for this program!
Objectives:
1. Identify recent outbreaks associated with endoscope reprocessing and analyze contributing factors.
2. Review the latest updates in guidelines and standards for endoscope processing, including AAMI, ISO and other relevant bodies.
3. Implement best practices and quality assurance measures to enhance the effectiveness and safety of endoscope reprocessing in healthcare facilities.

Dr. Mary Ann Drosnock
Director of Clinical Affairs
Healthmark, A Getinge company
Dr. Mary Ann Drosnock is the Director of Clinical Affairs at Healthmark, a Getinge company, where she provides expertise in medical device processing and infection prevention and leads an experienced team of Clinical Educators. For 9 years, she was co-chair of AAMI WG 84, which writes ST91, the national standard on flexible endoscope reprocessing, and TIR99 on the processing of ultrasound probes and dilators. Previous to Healthmark, Mary Ann managed the Infection Control Program for Olympus America, worked and managed labs as a pharmaceutical microbiologist, and taught Microbiology courses at the college level. MaryAnn has a B.S. in Biology, an M.S. in Quality and Regulatory Affairs, and a DrHSc in Healthcare Administration and Management. She is certified in Drug Development, Pharmaceutical Science, Infection Control, Flexible Endoscope Reprocessing, is a Nationally Certified Registered Microbiologist and is a fellow of both APIC and AAMI.
Key:




